Cerebral Palsy Upper Extremity Orthotic Device
Status
Conditions
Treatments
Details and patient eligibility
About
Upper extremity therapies for children with cerebral palsy (CP) have been validated for improving function in higher functioning patients. Those who function at the lowest end of the scale, on the Manual Ability Classification System scale (MACS) III-V, comprise 34-54% of the population, but as yet have no evidence-based interventions specific to their needs. Lower functioning children often retain some voluntary control of the elbow in spite of limited finger motion. A dynamic splint, or exoskeleton, could utilize the tenodesis effect from elbow motion to drive finger release while retaining flexor tone for grasp, potentially creating a portable, home-based therapeutic tool. The purpose of this study is to assess the effectiveness of an upper extremity orthotic device in improving the upper extremity function of children with cerebral palsy who have limited use of their hands.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- diagnosis of cerebral palsy, age 4-17 years, moderate-severe hand disability as graded by the Manual Ability Classification System, active movement of the elbow, ability to follow commands and participate in goal-making and repetitive tasks
Exclusion criteria
- mild or extremely severe hand disability, Botox or orthopaedic surgery within the past 6 months, severe contractures, lack of voluntary arm motion, unable to follow commands due to severe cognitive impairment
Trial design
Primary purpose
Allocation
Interventional model
Masking
36 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Alice Chu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal